Gradient Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-474
Closed -$7.7K 1189
2024
Q2
$7.7K Buy
474
+274
+137% +$4.45K ﹤0.01% 787
2024
Q1
$2.82K Sell
200
-951
-83% -$13.4K ﹤0.01% 807
2023
Q4
$12K Sell
1,151
-800
-41% -$8.35K ﹤0.01% 803
2023
Q3
$19.9K Buy
1,951
+800
+70% +$8.16K ﹤0.01% 682
2023
Q2
$8.67K Hold
1,151
﹤0.01% 833
2023
Q1
$10.2K Buy
1,151
+951
+476% +$8.42K ﹤0.01% 812
2022
Q4
$1.82K Sell
200
-800
-80% -$7.3K ﹤0.01% 1105
2022
Q3
$8K Hold
1,000
﹤0.01% 857
2022
Q2
$8K Hold
1,000
﹤0.01% 827
2022
Q1
$9K Buy
1,000
+800
+400% +$7.2K ﹤0.01% 801
2021
Q4
$2K Hold
200
﹤0.01% 1096
2021
Q3
$2K Hold
200
﹤0.01% 1033
2021
Q2
$2K Hold
200
﹤0.01% 1020
2021
Q1
$2K Sell
200
-132
-40% -$1.32K ﹤0.01% 1032
2020
Q4
$3K Hold
332
﹤0.01% 906
2020
Q3
$3K Buy
332
+132
+66% +$1.19K ﹤0.01% 911
2020
Q2
$2K Hold
200
﹤0.01% 916
2020
Q1
$2K Hold
200
﹤0.01% 938
2019
Q4
$2K Sell
200
-43
-18% -$430 ﹤0.01% 963
2019
Q3
$2K Buy
243
+43
+22% +$354 ﹤0.01% 943
2019
Q2
$2K Buy
+200
New +$2K ﹤0.01% 900
2018
Q2
Sell
-13
Closed 1134
2018
Q1
$0 Hold
13
﹤0.01% 1156
2017
Q4
$0 Buy
+13
New ﹤0.01% 1083
2017
Q3
Sell
-24,090
Closed -$800K 661
2017
Q2
$800K Buy
24,090
+16,386
+213% +$544K 0.06% 110
2017
Q1
$247K Buy
7,704
+7,500
+3,676% +$240K 0.02% 214
2016
Q4
$7K Buy
204
+194
+1,940% +$6.66K ﹤0.01% 506
2016
Q3
$0 Hold
10
﹤0.01% 775
2016
Q2
$0 Sell
10
-149
-94% ﹤0.01% 793
2016
Q1
$8K Buy
159
+59
+59% +$2.97K ﹤0.01% 473
2015
Q4
$7K Hold
100
﹤0.01% 447
2015
Q3
$6K Hold
100
﹤0.01% 438
2015
Q2
$6K Buy
100
+8
+9% +$480 ﹤0.01% 450
2015
Q1
$6K Buy
+92
New +$6K ﹤0.01% 473
2014
Q1
Sell
-63
Closed -$3K 623
2013
Q4
$3K Buy
+63
New +$3K ﹤0.01% 481